Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai High-tech United Biotechnology is a Chinese biopharmaceutical company focused on the development and commercialization of recombinant protein therapeutics for regenerative medicine. Founded as a strategic joint venture between the Shanghai Zhangjiang High-Tech Park and the Center for Genetic Engineering and Biotechnology (CIGB) of Cuba, the company leverages advanced genetic engineering to produce growth factors. Its primary product line includes Recombinant Human Epidermal Growth Factor (rhEGF), marketed under the brand names GeneTime for dermatology and GeneSoft for ophthalmology. These products are utilized in the treatment of burns, chronic wounds, and corneal injuries. The company maintains large-scale GMP manufacturing capabilities in Shanghai to support its domestic and international market presence.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanghai High-tech United Biotechnology Research and Development.